NDC 70518-4137-00 - Alprazolam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4137
- Requested NDC
- 70518-4137-00
- Package NDCs from labels
- 70518-4137-0, 70518-4137-00
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-08-27
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Alprazolam - REMEDYREPACK INC. | REMEDYREPACK INC. | 2026-08-27 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4137-0 | Alprazolam | 60 in 1 BOTTLE, PLASTIC | TABLET | 60 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-4137 | ALPRAZOLAM TABLET [REMEDYREPACK INC.] | 1 | Current NDC, 1 package rows | 20240712_563e09db-2f3d-4ce8-b356-ae44477be6d0.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stool Softener Laxative | DOCUSATE SODIUM | P & L Development, LLC | 1f6c3b64-0fcd-4cd3-9947-453d79468292 | 2026-01-19 | Warnings | F05Q2T2JA0 |
| DOCUSATE SODIUM | DOCUSATE SODIUM | WALGREEN COMPANY | 21fbddce-d3e7-4090-9e69-f4e07fa97ba2 | 2026-01-19 | Warnings | F05Q2T2JA0 |
| Lotrimin Daily Sweat and Odor Control | TOPICAL STARCH | Bayer HealthCare LLC. | 9ec5c80d-b550-496f-e053-2a95a90a5489 | 2026-01-16 | Warnings | O8232NY3SJ |
| Stool Softener | DOCUSATE SODIUM | TOP CARE (Topco Associates LLC) | 0ce164a5-6b2f-4a21-9dca-10301a1f812a | 2026-01-15 | Warnings | F05Q2T2JA0 |
| Dulcolax Pink Stool Softener | DOCUSATE SODIUM | Chattem, Inc. | 33fefcf1-9985-4797-9a38-8acaf3979fce | 2026-01-14 | Warnings | F05Q2T2JA0 |
| Stool Softener | DOCUSATE SODIUM | TOP CARE (Topco Associates LLC) | 92659389-c36f-499b-b284-5b520e50e9a6 | 2026-01-14 | Warnings | F05Q2T2JA0 |
| Alprazolam | ALPRAZOLAM | Natco Pharma USA LLC | b3c55877-2538-4892-bdb1-d618c643d29c | 2026-01-13 | Boxed warning, Warnings, Adverse reactions | 197321 308047 197322 308048 YU55MQ3IZY |
| Stool Softener Laxative | DOCUSATE SODIUM | Care One (Retail Business Services, LLC.) | 597d2e9c-1adb-4c7d-ada3-de5c2db69c74 | 2026-01-09 | Warnings | F05Q2T2JA0 |
| CitraNatal 90 DHA | VITAMIN C, CALCIUM, IRON, VITAMIN D3, VITAMIN E, THIAMIN, RIBOFLAVIN, NIACINAMIDE, VITAMIN B6, FOLIC ACID, IODINE, ZINC, COPPER, DOCUSATE SODIUM | Mission Pharmacal Company | 81e639d7-352e-4eaa-87d9-582da68b9728 | 2026-01-08 | Boxed warning, Warnings, Adverse reactions | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | CVS Pharmacy | c445864f-fc88-4885-9f40-d189b9dc4290 | 2026-01-07 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | United Natural Foods, Inc. dba UNFI | c46a1f7c-12e3-4be1-b9e4-d3edac0f4386 | 2026-01-07 | Warnings | F05Q2T2JA0 |
| Ferralet 90 | IRON, FOLIC ACID, CYANOCOBALAMIN, ASCORBIC ACID, AND DOCUSATE SODIUM | Mission Pharmacal Company | 0be2918e-55b3-4c66-aba0-09099a1c7770 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM | TOP CARE (Topco Associates LLC) | 44fe6ce0-5fed-418f-8a6a-d6132e288328 | 2026-01-07 | Warnings | F05Q2T2JA0 |
| Stool Softener | DOCUSATE SODIUM | Strategic Sourcing Services LLC | 24e29f00-f1cf-4e92-bd67-3f6f820af783 | 2026-01-07 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative Extra Strength | DOCUSATE SODIUM | P & L Development, LLC | 33000a06-e030-433a-8f9c-7ae5c08037fa | 2026-01-06 | Warnings | F05Q2T2JA0 |
| Stool Softener Regular Strength | DOCUSATE SODIUM | Sam's West, Inc | 1eca5910-b0bf-4e07-8211-36dba52b3de7 | 2026-01-06 | Warnings | F05Q2T2JA0 |
| Senna S | DOCUSATE SODIUM, SENNOSIDES | Safeway, Inc. | acb40b29-5fd5-4864-b6bf-4102e47a1683 | 2026-01-05 | Warnings | F05Q2T2JA0 |
| Senna-S | SENNOSIDES AND DOCUSATE SODIUM | RMT HEALTH LLC | 4742182e-fdf9-44fe-e063-6394a90adfcc | 2025-12-31 | Warnings | F05Q2T2JA0 |
| Docusate Sodium Liquid | DOCUSATE SODIUM | LLORENS PHARMACEUTICALS INTERNATIONAL DIVISION | 2d8bdd3e-f6e6-43f5-b3b0-e5a882cae41c | 2025-12-31 | Warnings | F05Q2T2JA0 |
| Senna-S | DOCUSATE SODIUM 50MG AND SENNOSIDES 8.6MG | Walgreens | 36cc3a5b-1891-d39e-e063-6294a90a93b4 | 2025-12-31 | Warnings | F05Q2T2JA0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.